Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Hematology/Oncology Clinics of North America
|
July 2, 2022
Chimeric Antigen Receptor T-cell Therapy: Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies
Aimee C Talleur, Regina Myers, Colleen Annesley, et al.
Pediatric Blood & Cancer
|
September 10, 2020
Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity
Gordon Cohen, Stacy Cooper, Edward Allan Sison, et al.
Journal for Immunotherapy of Cancer
|
November 19, 2025
CD28 signaling complexes are correlated with patient outcomes in anti-CD19 41BB-costimulation CAR T cell therapy
Isabella H Draper, William Selke, Samuel A Ritmeester-Loy, et al.
Transfusion
|
March 15, 2018
Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma
Francesco Ceppi, Julie Rivers, Colleen Annesley, et al.
Transplantation and Cellular Therapy
|
September 9, 2023
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia
Adam J Lamble, Amy Moskop, Michael A Pulsipher, et al.
Neuro-Oncology Practice
|
March 9, 2026
Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03
Rebecca Ronsley, Michelle Choe, Jason Wright, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Experimental Hematology
|
November 5, 2013
NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease
Rachel Rau, Daniel Magoon, Sarah Greenblatt, et al.
Transplantation and Cellular Therapy
|
October 13, 2021
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage
Corinne Summers, Qian Vicky Wu, Colleen Annesley, et al.
Transplantation and Cellular Therapy
|
May 21, 2025
Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia
Katelyn Burleigh, Kelly G Stratton, Jenny L Smith, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Hematology/Oncology Clinics of North America
|
July 2, 2022
Chimeric Antigen Receptor T-cell Therapy: Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies
Aimee C Talleur, Regina Myers, Colleen Annesley, et al.
Pediatric Blood & Cancer
|
September 10, 2020
Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity
Gordon Cohen, Stacy Cooper, Edward Allan Sison, et al.
Journal for Immunotherapy of Cancer
|
November 19, 2025
CD28 signaling complexes are correlated with patient outcomes in anti-CD19 41BB-costimulation CAR T cell therapy
Isabella H Draper, William Selke, Samuel A Ritmeester-Loy, et al.
Transfusion
|
March 15, 2018
Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma
Francesco Ceppi, Julie Rivers, Colleen Annesley, et al.
Transplantation and Cellular Therapy
|
September 9, 2023
INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia
Adam J Lamble, Amy Moskop, Michael A Pulsipher, et al.
Neuro-Oncology Practice
|
March 9, 2026
Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03
Rebecca Ronsley, Michelle Choe, Jason Wright, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Experimental Hematology
|
November 5, 2013
NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease
Rachel Rau, Daniel Magoon, Sarah Greenblatt, et al.
Transplantation and Cellular Therapy
|
October 13, 2021
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage
Corinne Summers, Qian Vicky Wu, Colleen Annesley, et al.
Transplantation and Cellular Therapy
|
May 21, 2025
Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia
Katelyn Burleigh, Kelly G Stratton, Jenny L Smith, et al.
Page
of 3